We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Age-Related Lack of Attachment Proteins Diminishes Regenerative Ability of Muscle Tissue

By LabMedica International staff writers
Posted on 20 Jul 2016
Print article
Image: A normal muscle (left) is compared to a muscle lacking beta1-integrin (right) (Photo courtesy of Chen-Ming Fan, Michelle Rozo / Carnegie Institution for Science).
Image: A normal muscle (left) is compared to a muscle lacking beta1-integrin (right) (Photo courtesy of Chen-Ming Fan, Michelle Rozo / Carnegie Institution for Science).
The cellular attachment proteins fibronectin and beta1-integrin have been linked to age-related changes that limit the ability of muscle tissue to regenerate and in the reduced maintenance of muscle stem cells.

Integrins are transmembrane receptors that mediate the attachment between a cell and the tissues that surround it, such as other cells or the extracellular matrix (ECM). Fibronectin is a high-molecular weight ECM glycoprotein that binds to attachment proteins such as integrins. Similar to integrins, fibronectin binds extracellular matrix components such as collagen, fibrin, and heparin sulfate proteoglycans.

Investigators at the Carnegie Institution for Science (Baltimore, MD, USA) and colleagues at the École Polytechnique Fédérale de Lausanne (Switzerland) combined efforts to study the molecular basis for the detrimental effects of aging on muscle tissue.

They reported in two papers published in the July 4, 2016, online edition of the journal Nature Medicine that there was a strong link between the action of beta1-integrin and fibronectin in the deterioration of muscle during aging. Beta1-integrin was found to be diminished in aged muscle stem cells (MuSCs). Artificial removal of beta1-integrin from youthful muscles caused them to behave as if they were old, while activation of beta1-integrin in mice with aged muscles restored their regenerative abilities to youthful levels.

Similarly, the aged stem cell niche in skeletal muscle contained substantially reduced levels of fibronectin (FN), leading to detrimental consequences for the function and maintenance of MuSCs. Deletion of the gene encoding FN from young regenerating muscles replicated the aging phenotype and led to a loss of MuSC numbers. Reconstitution of FN levels in the aged niche remobilized stem cells and restored youth-like muscle regeneration. Improvement in regeneration, strength, and function were also seen when this treatment was applied to animals with muscular dystrophy.

"Inefficient muscular healing in the elderly is a significant clinical problem and therapeutic approaches are much needed, especially given the aging population-and, I am including myself in this population," said senior author Dr. Chen-Ming Fan, researcher in the department of embryology at the Carnegie Institution for Science. "Finding a way to target muscle stem cells could greatly improve muscle renewal in older individuals. Taken together, our results show that aged muscle stem cells with compromised beta1-integrin activity and aged muscles with insufficient amount of fibronectin are both root causes of muscle aging. This makes beta1-integrin and fibronectin very promising therapeutic targets."

Related Links:
Carnegie Institution for Science
École Polytechnique Fédérale de Lausanne
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.